FAUST PHARMACEUTICALS
Founder
More informations about "Faust Pharmaceuticals"
Faust changes name to Domain Therapeutics - Pharmaceutical …
Dec 15, 2008 Faust changes name to Domain Therapeutics. faust, changes, name, domain, therapeutics, french, clinical-stage. Sunday 1 September 2024. About. Contact. ... French …See details»
Faust Pharmaceuticals - In Vivo
Jan 1, 2002 Strasbourg, France-based Faust Pharmaceuticals aims to identify and develop small molecule drug candidates that can modulate the level of neurotransmitters in the brain to …See details»
Faust Pharmaceuticals Obtains $2.6M To Develop CNS Drugs
Apr 24, 2002 Faust Pharmaceuticals, which operates out of Gif-sur-Yvette, was created in October and is an offshoot of the French National Scientific Research Center’s Cellular and …See details»
Faust Pharmaceuticals - Drug pipelines, Patents, Clinical trials
Explore Faust Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 news, and 2 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for …See details»
Faust changes name to Domain Therapeutics - insights.citeline.com
Faust Pharmaceuticals has changed its name to Domain Therapeutics to reflect its new business model and activities better. The company was previously focused on its G protein-coupled …See details»
Faust Pharmaceuticals - Les Echos
Oct 25, 2006 Faust Pharmaceuticals. Ajouter à mes articles. Commenter. Partager. Partager. 10. Publié le 25 oct. 2006 à 01:01. Date de création : 2001 PDG : Thomas C. Seoh Effectif : …See details»
Faust Pharmaceuticals - Crunchbase
Faust PharmaceuticalsSee details»
Faust Pharmaceuticals:Company Profile & Technical …
Feb 13, 2023 Faust Pharmaceuticals has a total of 33 patents . Login to view all basic info. Data Snapshot. 33. Patent. 6. News. High Related Markets. Mentioned companies in the market …See details»
Domain Therapeutics succède à Faust | Capital Finance
Jan 12, 2009 Rebaptisée Domain Therapeutics, l'ex-Faust Pharmaceuticals a augmenté son capital de 2,11 M Euros, ce qui lui donne les moyens de se relancer avec un nouveau modèle …See details»
FAUST PHARMACEUTICALS innovation strategy - GoodIP
FAUST PHARMACEUTICALS has a total of 31 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO …See details»
Faust Pharmaceuticals (Switzerland) SA, Plan-les-Ouates, Schweiz
Faust Pharmaceuticals (Switzerland) SA, Plan-les-Ouates, Schweiz, Schweizer Handelsregister CHE-112.155.503: WirtschaftsinfosSee details»
Faust Pharmaceuticals devient Domain Therapeutics - L'Usine …
Faust Pharmaceuticals, une société dédiée à l'identification de molécules se fixant sur les récepteurs couplés aux protéines G (GPCR), change de nom et devient Domain Therapeutics.See details»
Faust Pharmaceuticals | Science|Business
Faust Pharmaceuticals. Faust seals research pact with Takeda. 09 Jan 2008. Health. Subscribe to Faust Pharmaceuticals Funding Newswire subscription. Follow where the public and private R&I money is going and which collaborative opportunities you can pursue. Subscribe today. Log in.See details»
Faust Pharma closes 8.2M euro financing - Pharmaceutical …
Oct 15, 2006 Faust Pharma closes 8.2M euro financing 15 October 2006 Strasbourg, France-headquartered Faust Pharmaceuticals, a clinical-stage product company specializing in the …See details»
Faust Pharma se relance sous le nom de Domain Therapeutics
Dec 15, 2008 Date de création : 2001 Président : Bernard Gilly Effectif : 11 personnes Montant levé : 2,11 millions d'euros Chiffre d'affaires 2007 : NC www.domaintherapeutics.com Après …See details»
FP 0011 - AdisInsight - Springer
Nov 20, 2009 FP 0011 is a small molecule glutamate release inhibitor that was being developed in clinical trials by Faust Pharmaceuticals (later Domain Therapeutics) in FP 0011 Next ... If …See details»
Christophe Bancel - Founder & CEO @ TISSIUM - Crunchbase
Primary Organization . TISSIUM . Location Paris, Ile-de-France, France; Regions European Union (EU), Europe, Middle East, and Africa ... as Business Developer at Transgene and then was a …See details»
Patents Assigned to FAUST PHARMACEUTICALS - Justia Patents …
Applicant: FAUST PHARMACEUTICALS Inventors: Stephan Schann, Stanislas Mayer, Sophie Gardan Methods for the prevention and/or the treatment of neurological disorders. Publication number: 20040014648 Abstract: The present invention relates to the use of substrates of an UDP-glucuronosyltransferase (UGT) and salts thereof, for the prevention and ...See details»
Faust Pharmaceuticals (Switzerland) SA, en liquidation - Lixt
Faust Pharmaceuticals (Switzerland) SA, en liquidation in Plan-les-Ouates | Gelöscht 2007 | Gegründet 2004 | Management: Berdat Nicolas, PricewaterhouseCoopers SA, succursale à …See details»